Initial Performance Evaluation of a Spotted Array Mobile Analysis Platform (MAP) for the Detection of Influenza A/B, RSV and MERS Coronavirus
Clinical samples were evaluated with the Mobile Analysis Platform (MAP) to determine platform performance for detecting respiratory viruses in samples previously characterized using clinical RT-PCR assays. The percent agreement between MAP and clinical results was 97% for influenza A (73/75), 100% (21/21) for influenza B, 100% (6/6) for RSV, and 80% (4/5) for negative specimens. The approximate LOD of the MAP was 30 copies /assay for RSV and 1500 copies/assay for MERS Coronavirus.
Source: Diagnostic Microbiology and Infectious Disease - Category: Microbiology Authors: Justin Hardick, David Metzgar, Lisa Risen, Christopher Myers, Melinda Balansay, Trent Malcom, Richard Rothman, Charlotte Gaydos Tags: Note Source Type: research
More News: Coronavirus | Infectious Diseases | Influenza | MERS | Microbiology | Respiratory Medicine